Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
Abstract Background Kawasaki disease (KD) is an acute febrile systemic vasculitis most commonly seen in children under 5 years old. High-dose aspirin is often administered, but the duration of such treatment varies. Many centers reduce the aspirin dose once the patient is afebrile, even before treat...
Main Authors: | Ho-Chang Kuo, Mindy Ming-Huey Guo, Mao-Hung Lo, Kai-Sheng Hsieh, Ying-Hsien Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-018-1180-1 |
Similar Items
-
Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01) -
Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
by: Donato Rigante, et al.
Published: (2016-02-01) -
Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020-11-01) -
Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
by: Min Seob Song
Published: (2019-04-01) -
Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021-09-01)